{
    "paper_id": "d3e7ec04c24315ed1f14b9bddd84ac091a8a22a8",
    "metadata": {
        "title": "Funding 85 National Natural Science Foundation of China (No. 81822011, 81771013). 86 University of Miami COVID-19 Rapid Response Grant",
        "authors": [
            {
                "first": "Chenghao",
                "middle": [],
                "last": "Qiu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Chong",
                "middle": [],
                "last": "Cui",
                "suffix": "",
                "affiliation": {
                    "laboratory": "ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT 17 Hospital, State Key Laboratory of Medical Neurobiology",
                    "institution": "Fudan University",
                    "location": {
                        "addrLine": "19 20",
                        "postCode": "200031",
                        "settlement": "Shanghai",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Charlotte",
                "middle": [],
                "last": "Hautefort",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Antje",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jun",
                "middle": [],
                "last": "Haehner",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Qi",
                "middle": [],
                "last": "Zhao",
                "suffix": "",
                "affiliation": {
                    "laboratory": "The Third People's Hospital of Shenzhen29",
                    "institution": "Huazhong University of Science and Technology",
                    "location": {
                        "addrLine": "30 China. 31 32 7., Wuhan, 34 430022, China. 35 36 8., 37 Bulan Road, Longgang District",
                        "postCode": "201508, 518112",
                        "settlement": "Shanghai, Shenzhen",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Yao",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "7#",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Hui",
                "middle": [],
                "last": "Zeng",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Eric",
                "middle": [
                    "J"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Li",
                "middle": [],
                "last": "Nisenbaum",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Liu",
                "suffix": "",
                "affiliation": {},
                "email": "xliu@med.miami.edu"
            },
            {
                "first": ";",
                "middle": [
                    "Yu"
                ],
                "last": "Zhao",
                "suffix": "",
                "affiliation": {
                    "laboratory": "ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT 17 Hospital, State Key Laboratory of Medical Neurobiology",
                    "institution": "Fudan University",
                    "location": {
                        "addrLine": "19 20",
                        "postCode": "200031",
                        "settlement": "Shanghai",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Di",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "The Third People's Hospital of Shenzhen29",
                    "institution": "Huazhong University of Science and Technology",
                    "location": {
                        "addrLine": "30 China. 31 32 7., Wuhan, 34 430022, China. 35 36 8., 37 Bulan Road, Longgang District",
                        "postCode": "201508, 518112",
                        "settlement": "Shanghai, Shenzhen",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Corinna",
                "middle": [
                    "G"
                ],
                "last": "Levine",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ivette",
                "middle": [],
                "last": "Cejas",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Qi",
                "middle": [],
                "last": "Dai",
                "suffix": "",
                "affiliation": {
                    "laboratory": "ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT 17 Hospital, State Key Laboratory of Medical Neurobiology",
                    "institution": "Fudan University",
                    "location": {
                        "addrLine": "19 20",
                        "postCode": "200031",
                        "settlement": "Shanghai",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Mei",
                "middle": [],
                "last": "Zeng",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Philippe",
                "middle": [],
                "last": "Herman",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Clement Jourdaine",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Katja De With",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Julia",
                "middle": [],
                "last": "Draf",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Bing",
                "middle": [],
                "last": "Chen",
                "suffix": "",
                "affiliation": {
                    "laboratory": "ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT 17 Hospital, State Key Laboratory of Medical Neurobiology",
                    "institution": "Fudan University",
                    "location": {
                        "addrLine": "19 20",
                        "postCode": "200031",
                        "settlement": "Shanghai",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Dushyantha",
                "middle": [
                    "T"
                ],
                "last": "Jayaweera",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "James",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "C",
                "middle": [],
                "last": "Denneny",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": ";",
                "middle": [
                    "Roy"
                ],
                "last": "Casiano",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Hongmeng",
                "middle": [],
                "last": "Yu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT 17 Hospital, State Key Laboratory of Medical Neurobiology",
                    "institution": "Fudan University",
                    "location": {
                        "addrLine": "19 20",
                        "postCode": "200031",
                        "settlement": "Shanghai",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Adrien",
                "middle": [
                    "A"
                ],
                "last": "Eshraghi",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Thomas",
                "middle": [],
                "last": "Hummel",
                "suffix": "",
                "affiliation": {},
                "email": "thummel@msx.tu-dresden.de"
            },
            {
                "first": "Xuezhong",
                "middle": [],
                "last": "Liu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT 17 Hospital, State Key Laboratory of Medical Neurobiology",
                    "institution": "Fudan University",
                    "location": {
                        "addrLine": "19 20",
                        "postCode": "200031",
                        "settlement": "Shanghai",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Yilai",
                "middle": [],
                "last": "Shu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT 17 Hospital, State Key Laboratory of Medical Neurobiology",
                    "institution": "Fudan University",
                    "location": {
                        "addrLine": "19 20",
                        "postCode": "200031",
                        "settlement": "Shanghai",
                        "country": "China"
                    }
                },
                "email": "yilai_shu@fudan.edu.cn7374"
            },
            {
                "first": "Hongzhou",
                "middle": [],
                "last": "Lu",
                "suffix": "",
                "affiliation": {},
                "email": "luhongzhou@fudan.edu.cn83"
            },
            {
                "first": "Antje",
                "middle": [],
                "last": "Haehner",
                "suffix": "",
                "affiliation": {
                    "laboratory": "NHC Key Laboratory of Hearing Medicine",
                    "institution": "Fudan University",
                    "location": {
                        "addrLine": "21 China. 22 23 4",
                        "postCode": "200031",
                        "settlement": "Shanghai"
                    }
                },
                "email": ""
            },
            {
                "first": "Jun",
                "middle": [],
                "last": "Zhao",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Qi",
                "middle": [],
                "last": "Yao",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Hui",
                "middle": [],
                "last": "Zen",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Li",
                "middle": [],
                "last": "Liu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Qi",
                "middle": [],
                "last": "Cejas",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Katja",
                "middle": [],
                "last": "Dai",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Julia",
                "middle": [],
                "last": "De With",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Bing",
                "middle": [],
                "last": "Draf",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Dushyantha",
                "middle": [
                    "T"
                ],
                "last": "Chen",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "James",
                "middle": [],
                "last": "Jayaweera",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Roy",
                "middle": [],
                "last": "Casiano",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "interpretation of data, 102 writing, revising it critically. All of them agreement to be accountable for all aspects of 103 the work in ensuring that questions related to the accuracy or integrity of any part of 104 the work are appropriately investigated and resolved. 105 106 Abstract 123 Objective: Evaluate the prevalence and characteristics of olfactory or gustatory 124 dysfunction in COVID-19 patients 125 Study Design: Multicenter Case Series 126 Setting: 5 tertiary care hospitals (3 in China, 1 in France, 1 in Germany) 127 Subjects and Methods: 394 PCR confirmed COVID-19 positive patients were 128",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "screened, and those with olfactory or gustatory dysfunction were included. Data 129",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "including demographics, COVID-19 severity, patient outcome, and the incidence and 130",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "degree of olfactory and/or gustatory dysfunction were collected and analyzed. The 131",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Questionnaire of Olfactory Disorders (QOD) and Visual Analogue Scale (VAS) were 132 used to quantify olfactory and gustatory dysfunction respectively. All subjects at one 133 hospital (Shanghai) without subjective olfactory complaints underwent objective 134",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "testing. 135 Results: Of 394 screened subjects, 161 (41%) reported olfactory and/or gustatory 136 dysfunction and were included. Incidence of olfactory and/or gustatory disorders in 137 Chinese (n=239), German (n=39) and French (n=116) cohorts were 32%, 69%, and 49% 138 respectively. The median age of included subjects was 39 years old, 92/161 (57%) were 139 male, and 10/161 (6%) were children. Of included subjects, 10% had only olfactory or 140 gustatory symptoms\uff0cand 19% had olfactory and/or gustatory complaints prior to any 141 other COVID-19 symptom. Of subjects with objective olfactory testing, 10/90 142 demonstrated abnormal chemosensory function despite reporting normal subjective 143 olfaction. 43% (44/102) of subjects with follow-up showed symptomatic improvement 144",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "in olfaction or gustation. 145",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Conclusions: Olfactory and/or gustatory disorders may represent early or isolated 146 symptoms of SARS-CoV-2 infection. They may serve as a useful additional screening 147 criterion, particularly for the identification of patients in the early stages of infection.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "The global spread of SARS-CoV-2 is fast-moving and ongoing, with more than three 166 million cases reported across 214 countries and regions. 1 The main clinical symptoms 167 of COVID-19 patients are fever, dry cough, and fatigue. Patients may also present with 168 less typical symptoms including nasal congestion, rhinorrhea, sore throat, myalgia, and 169 diarrhea. 2 Recently reports from a number of countries indicate that olfactory or 170 gustatory dysfunction may also be one of the initial presenting symptoms in a large 171 number of COVID-19 patients. 3 A study of COVID-19 inpatients in Wuhan 172 demonstrated that 5.1% (11/214) patients experienced hyposmia, and 5.6% (12/214) 173 patients exhibited hypogeusia. 4 An Italian study found that 33.9% of COVID-19 174 confirmed inpatients presented with at least one olfactory or gustatory symptom. 5 A 175 study of patients with influenza-like symptoms showed that COVID-19 positive 176 patients have a high prevalence of olfactory or gustatory disorders compared with 177 COVID-19 negative patients. 6 Olfactory and gustatory disorders were also found to be 178 prevalent symptoms in COVID-19 patients in a multicenter European study. 7 The 179",
            "cite_spans": [
                {
                    "start": 142,
                    "end": 143,
                    "text": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 368,
                    "end": 369,
                    "text": "2",
                    "ref_id": null
                },
                {
                    "start": 1060,
                    "end": 1061,
                    "text": "6",
                    "ref_id": null
                },
                {
                    "start": 1195,
                    "end": 1196,
                    "text": "7",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) 180 developed an anosmia reporting tool that was opened to contributors on March 26,2020 181 and the initial findings were reported on 237 patients worldwide. There are now over 182 800 patients submitted through this tool. Anosmia was the sentinel symptom in over 183 25% of the patients and occurred in over two-thirds of the patients. 8 Some patients with 184 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020 . . https://doi.org/10.1101 mild symptoms may only have changes in olfaction or gustation and so may be 185 overlooked in screening and testing efforts, leading to further disease spread. 186",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 16, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "However, the documented prevalence of olfactory or gustatory disorders differs greatly 187 between studies, and little is known about how this may vary based on factors such as 188 age, disease severity, and between multiple different countries and/or ethnic 189 populations. To remedy this, we studied the association between olfactory and 190 gustatory complaints and early SARS-CoV-2 infections at 5 hospitals in China, 191 Germany France) initially diagnosed by RT-PCR from oro-or nasopharyngeal swab specimens 202 were screened. All 394 patients were asked about loss of olfaction and/or gustation and 203 161 patients presenting with olfactory and/or gustatory dysfunction were identified and 204 enrolled in this study, with final follow-up obtained on April 5 th , 2020. Hospitals 205 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [
                {
                    "start": 416,
                    "end": 422,
                    "text": "China,",
                    "ref_id": null
                },
                {
                    "start": 423,
                    "end": 426,
                    "text": "191",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020 . . https://doi.org/10.1101 included in the study were as follows: For the test, three disposable cotton swabs dipped in each of these stimuli were placed 224 1-2 cm below the front nostril of the subjects, who were instructed to smell 3 times. A 225 VAS of gustatory intensity was used to assess the presence and degree of hypogeusia. 226 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 16, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020 . . https://doi.org/10.1101 Disease severity was classified as follows. Asymptomatic patients indicates that there 227 were no clinically identifiable or self-perceived signs or symptoms of infection at the 228 time of positive SARS-CoV-2 PCR testing. Patients classified as mild presented with 229 only low fever, mild cough, slight fatigue, and no evidence of pneumonia on CT 230",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 16, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "imaging. Patients classified as moderate had fever and respiratory symptoms, and 231",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "imaging showed evidence of pneumonia. Patients classified as severe had dyspnea, 232 respiratory frequency \u226530/min, blood oxygen saturation \u226493%, partial pressure of 233 arterial oxygen to fraction of inspired oxygen ratio \u2264300mmHg or pulmonary CT 234",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "imaging showing at least a 50% increase in infiltrate volume over 24-48 hours. Patients 235 classified as critical had respiratory failure, septic shock, and/or multiple organ 236 dysfunction or failure. 2 237 Clinical, treatment, and outcome data were obtained from data collection forms in the 238 electronic medical records. The data were analyzed and reviewed by a team of trained 239 physicians. The recorded information included demographic data, comorbidities, 240 severity classification, patient outcomes, the degree of olfactory or gustatory loss and 241 the incidence of the symptom in COVID-19 patients. A descriptive analysis was 242 performed. Categorical variables were described as frequency rates and percentages, 243 and continuous variables were described using mean, median, standard deviation (SD) 244 and interquartile range (IQR) values. A pairwise comparison of data from the three 245 countries was made to assess for demographic heterogeneity and examine differences 246 in the prevalence and characteristics of olfactory and gustatory symptoms. Independent 247 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020 . . https://doi.org/10.1101 group t tests and chi-square tests were used for continuous variables and categorical 248 variables, respectively. Fisher exact test was used when the data were limited. All 249 statistical analyses were performed using SPSS (Statistical Package for the Social 250 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 16, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020 . . https://doi.org/10.1101 respectively. The severity classification among all COVID-19 patients in France was 269",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 16, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Introduction 165"
        },
        {
            "text": "Among the 161 included patients who had sudden olfactory or gustatory loss, median 271 age was 38.8\u00b117.6 years (IQR, 23-53 years) and 92/161 (57%) were male. Distribution 272 of age in these enrolled patients was significantly different between China and the two 273 The percentage of patients presenting with olfactory or gustatory disorders as their first 288 symptom of infection in China, Germany and France were 23%, 15% and 15%, 289 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "unavailable. 270"
        },
        {
            "text": "(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "unavailable. 270"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020 . . https://doi.org/10.1101 respectively. Olfactory or gustatory symptoms occurred simultaneously with classic 290 COVID-19 symptoms such as fever, cough, sore throat and diarrhea in 30 of 156 (19%) 291 patients (Table 1) . A single patient developed hearing loss during the course of their 292",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 16, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 284,
                    "end": 293,
                    "text": "(Table 1)",
                    "ref_id": null
                }
            ],
            "section": "unavailable. 270"
        },
        {
            "text": "In a subset of patients we were able to evaluate olfactory or gustatory function using 294 the olfactory VAS (n=113), the gustatory VAS (n=46) and the QOD (n=60). The mean 295 VAS scores of patients with olfactory or gustatory dysfunction were 3.60\u00b13.62 (IQR 296 0-7) and 4.46\u00b12.90 (IQR 2.25-6), respectively. The mean scores of QOD-QoL (quality 297 of life) were 37%\u00b123% (IQR 18%-49%), QOD-DS (socially desired statements) were 298 41%\u00b115% (IQR 32%-50%), and QOD-P (parosmic statements) were 40%\u00b130% (IQR 299 17%-60%) ( Table 2) . Of the 90 patients without subjective olfactory dysfunction in the 300 Shanghai, China cohort who were tested with the three chemosensory stimuli, 10 (9 301 adults and 1 child) showed abnormal chemosensory function. Eight of the ten patients 302 could not smell the three stimuli at all, while the other two could smell an odor but 303 could not distinguish the type of odor. These eight patients who could not perceive 304 vinegar and 75% ethanol may also have a trigeminal deficit. 305",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 521,
                    "end": 529,
                    "text": "Table 2)",
                    "ref_id": "TABREF2"
                }
            ],
            "section": "COVID-19 infection. 293"
        },
        {
            "text": "Of the 102 patients for whom follow-up data was available (time range for follow-up 306 was 3 weeks), 44 of 102 (43%) patients had improvement of their olfactory or gustatory 307 dysfunction, with the other 58 (57%) showing no improvement (including 3 deaths 308 among the critical cases). There was no significant difference in the outcome of 309 olfactory and/or gustatory disorders between Chinese and French COVID-19 patients 310 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "COVID-19 infection. 293"
        },
        {
            "text": "(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "COVID-19 infection. 293"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020. . https://doi.org/10.1101/2020.05.13.20100198 doi: medRxiv preprint (P=0.715). Follow-up data was not available for the German cohort, and was available 311 for only 25 patients in the French cohort (Table 1) . 312",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 272,
                    "end": 281,
                    "text": "(Table 1)",
                    "ref_id": null
                }
            ],
            "section": "COVID-19 infection. 293"
        },
        {
            "text": "Of 27 COVID-19 positive children who were screened (range of age 6-17 years), 10 313 (37%) children with olfactory or gustatory dysfunction were included. The age of these 314 10 patients ranged from 15 to 17 years old, and six of 10 (60%) were male. Seven 315 children (3 mild cases, 4 moderate cases) had both hyposmia and hypogeusia. Only 316 eight of the 10 patients were able to report the sequencing of their symptoms. Of these 317 eight, two patients (25%) had hyposmia and/or hypogeusia as their only symptom, and 318",
            "cite_spans": [],
            "ref_spans": [],
            "section": "COVID-19 infection. 293"
        },
        {
            "text": "both were found to have infected their family member prior to diagnosis. An additional 319 hospitalized child who did not report any subjective olfactory symptoms was also found 320 to have subclinical olfactory dysfunction when tested with the olfactory reagents. Three 321 of 9 (33%) children showed total symptomatic improvement during the observation 322 period. Follow-up was not obtained for one child in the German cohort (Table 3) . 323 324",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 429,
                    "end": 438,
                    "text": "(Table 3)",
                    "ref_id": "TABREF3"
                }
            ],
            "section": "COVID-19 infection. 293"
        },
        {
            "text": "This study systematically studied the incidence and characteristics of sensory 326 dysfunction among COVID-19 patients. It is the first to examine olfactory and/or 327 gustatory dysfunction in infected children. In our cohort of 394 COVID-19 patients, 41% 328 presented with olfactory and/or gustatory disorders, of whom approximately half were 329 mildly symptomatic. The incidence of olfactory or gustatory disorders in COVID-19 330 patients in Germany (69%) and France (49%) were significantly higher than in China 331 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Discussion 325"
        },
        {
            "text": "(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Discussion 325"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020 . . https://doi.org/10.1101 (32%, P\uff1c0.001 and P=0.002 respectively). A recent study also found that different 332 variants of SARS-CoV-2 are predominant outside of East Asia (\"Type A\" and \"Type 333 C\") compared to within East Asia (\"Type C\"). 10 It is possible that phenotypic 334 characteristics -including incidence of olfactory and gustatory disorders -may differ 335 between these variants. There is also the possibility that the incidence of olfactory or 336 gustatory disorders may vary based on ethnicity. However, given that there was also a 337 smaller but significant different between the German and French groups (P=0.029), it 338 is possible that the differences reflect other sources of heterogeneity between the groups 339 such as subject age, as the median age of German and French groups showed significant 340 difference with Chinese group (P=0.001 and P\uff1c0.001 respectively). Interestingly, the 341 distribution of COVID-19 disease severity among included subjects varied significantly 342 when comparing the three country cohorts to each other, which may indicate that 343 presence of olfactory or gustatory symptoms are not related to overall disease severity. 344",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 16, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Discussion 325"
        },
        {
            "text": "Olfactory or gustatory symptoms were the first and only symptoms in 10% of patients, 345 and 19% of patients experienced olfactory or gustatory dysfunction prior to any other 346 COVID-19 symptoms. In addition, 25% of children had only olfactory or gustatory 347 symptoms at COVID-19 presentation. This indicates that olfactory or gustatory 348 disorders are early identifiers of COVID-19 in a subset of patients, and thus has 349 important implications for patient screening and disease control. 350",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Discussion 325"
        },
        {
            "text": "Despite still being infectious, a significant portion of COVID-19 patients may be 351 minimally or atypically symptomatic early in the course of the disease, with one study 352 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Discussion 325"
        },
        {
            "text": "(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Discussion 325"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020 . . https://doi.org/10.1101 finding that less than 50% of early patients are febrile. 11 These patients may be missed 353 by screening initiatives focused on \"classic\" symptoms such as fever and cough, 354 delaying diagnosis, undermining triage and quarantine efforts, and leading to higher 355 rates of disease transmission. At least two mild patients in our study who presented with 356 applied. Notably, there were 10 subjects (9 adults and 1 child) who reported that they 364 had no olfactory dysfunction, but demonstrated signs of subclinical hyposmia when 365 exposed to three chemosensory stimuli. This may suggest that screening based on self-366 reported symptoms alone is not sufficient, considering the relatively high degree of 367 erroneous self-ratings with respect to the chemical senses. 12 However, it is not certain 368 if any of these patients had unrecognized pre-existing smell and/or taste disorders 369 unrelated to Recent studies have shed light on the mechanisms that may underlie the loss of olfaction 371 or gustation. SARS-CoV-2 has been found to replicate particularly well in the nose, 372",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 16, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Discussion 325"
        },
        {
            "text": "with high viral loads detected there soon after symptom onset. 13 ACE2 -the main host 373 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Discussion 325"
        },
        {
            "text": "(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Discussion 325"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020 . . https://doi.org/10.1101 cell receptor of SARS-CoV-2 -and TMPRSS2 -a cell surface protease involved in 374 SARS-CoV-2 cell entry -are highly expressed in a variety of olfactory epithelial cell 375 types, raising the possibility that viral invasion of these cells may lead to anosmia. 14,15 376",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 16, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Discussion 325"
        },
        {
            "text": "It has also been suggested that transcribiform viral spread and infection of more 377 proximal elements of the olfactory pathway via CNS ACE2 receptors may also 378 contribute to olfactory dysfunction. 16, 17 Alternatively, it is possible that at least some of 379 the olfactory dysfunction is conductive -secondary to nasal congestion, swelling, or 380 inflammation preventing olfactory molecules from reaching the olfactory cleft -rather 381 than sensorineural. 18 This may be particularly true in the subset of patients who showed 382 improvement of their olfactory dysfunction on follow-up, though further research is 383 needed. ACE2 is also highly expressed on the oral mucosa and tongue, representing a 384 potential mechanism for gustatory dysfunction. 19 385",
            "cite_spans": [
                {
                    "start": 202,
                    "end": 205,
                    "text": "16,",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 206,
                    "end": 208,
                    "text": "17",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Discussion 325"
        },
        {
            "text": "In addition to the much more common olfactory and gustatory sensory deficits, we 386",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Discussion 325"
        },
        {
            "text": "identified new onset hearing loss in one severely ill patient. While more research is 387 needed, this suggests that we should also be alert for other sensory deficits in addition 388 to hyposmia and dysgeusia, particularly given SARS-CoV-2's ability to invade the 389 CNS. 390 391",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Discussion 325"
        },
        {
            "text": "As with any retrospective study, the conclusions that can be drawn are limited by the 393 heterogeneous nature of the data available. Likewise, due to the impact of the COVID-394 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Limitations 392"
        },
        {
            "text": "(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Limitations 392"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020 . . https://doi.org/10.1101 19 pandemic and the difficulties inherent to a retrospective multi-institutional and 395",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 16, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Limitations 392"
        },
        {
            "text": "international study, there are differences in data collection methods and patient 396 populations between institutions that make drawing direct comparisons for some 397 measures more difficult. Olfactory and gustatory function have not been measured 398 psychophysically in COVID-19 positive patients, so it is possible that patients may have 399 confused gustatory and retronasal olfactory function, which would result in biased 400 ratings of olfactory or gustatory function. In addition, the subjective perception of 401 olfactory function is confounded by nasal breathing. Finally, symptom timeline often 402 relies on patient report of their symptoms and is subject to recall bias. To address these 403",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Limitations 392"
        },
        {
            "text": "issues, future prospective studies are necessary. 404 405",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Limitations 392"
        },
        {
            "text": "Olfactory and/or gustatory dysfunction may represent early or even the only symptom 407 of SARS-CoV-2 infection in both adults and children. As such, they may serve as 408 important screening criteria for identifying otherwise oligosymptomatic or atypically 409 symptomatic patients missed by other screening measures. We recommend that 410 questions related to olfactory and gustatory changes be added to routine screening 411 measures to help identify these patients prior to further disease transmission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusion 406"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020 May 16, . . https://doi.org/10.1101 May 16, /2020 doi: medRxiv preprint b three patients in France could not remember the date of onset of olfactory or gustatory 506 dysfunction. c the patients'improvement in Germany is unavailable. d only 25 patients 507",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 16, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 107,
                    "text": "May 16, . . https://doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 108,
                    "end": 121,
                    "text": "May 16, /2020",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Conclusion 406"
        },
        {
            "text": "were followed in France. e three critical patients died of COVID-19. f statistics for 508",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusion 406"
        },
        {
            "text": "China(77 cases) and France(25 cases) .  509  510  511  512  513  514  515  516  517  518  519  520  521  522  523  524  525  526  527  528  529  530  531  532  533  534  535  536  537  538  539  540  541  542  543  544  545  546 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 37,
                    "end": 228,
                    "text": ".  509  510  511  512  513  514  515  516  517  518  519  520  521  522  523  524  525  526  527  528  529  530  531  532  533  534  535  536  537  538  539  540  541  542  543  544  545  546",
                    "ref_id": "TABREF2"
                }
            ],
            "section": "Conclusion 406"
        },
        {
            "text": "(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusion 406"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020 . . https://doi.org/10.1101 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 16, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Conclusion 406"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020 . . https://doi.org/10.1101 Non-improved 6/9(67%) b",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 16, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Conclusion 406"
        },
        {
            "text": "Abbreviations: SD, standard deviation; IQR, interquartile range a two children could 584 not remember the date of onset of olfactory or gustatory dysfunction. b follow-up was 585 not obtained for one child in the German cohort. 586 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusion 406"
        },
        {
            "text": "(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusion 406"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 16, 2020 . . https://doi.org/10.1101 ",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 16, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Conclusion 406"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "JHU)-Cumulative Confirmed Cases",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Diagnosis and treatment plan for pneumonitis associated with new coronavirus infection 425 (trial version 7): General Office of the National Health Council and the Office of the State 426 Administration of Traditional Chinese Medicine",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Loss of sense of smell as marker of COVID-19 infection. ENT UK at The Royal College of 430 Surgeons of England",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Neurologic Manifestations of Hospitalized Patients With 434",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mao",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Jin",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Coronavirus Disease",
            "authors": [],
            "year": 2019,
            "venue": "",
            "volume": "435",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Self-reported olfactory and taste disorders in SARS-437",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Giacomelli",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Pezzati",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Conti",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "CoV-2 patients: a cross-sectional study",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1093/cid/ciaa330"
                ]
            }
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Association of chemosensory 440 dysfunction and Covid-19 in patients presenting with influenza-like symptoms",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "H"
                    ],
                    "last": "Yan",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Faraji",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "P"
                    ],
                    "last": "Prajapati",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "E"
                    ],
                    "last": "Boone",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Deconde",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Olfactory and gustatory dysfunctions as 444 a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a 445 multicenter European study",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Lechien",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Chiesa-Estomba",
                    "suffix": ""
                },
                {
                    "first": "De",
                    "middle": [],
                    "last": "Siati",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "R"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "COVID-19 Anosmia Reporting 448 Tool: Initial Findings",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Kaye",
                    "suffix": ""
                },
                {
                    "first": "Cwd",
                    "middle": [],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kazahaya",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Brereton",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Denneny",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Otolaryngology-Head and Neck Surgery",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Olfactory dysfunction and daily life",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Frasnelli",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Hummel",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Eur Arch Otorhinolaryngol",
            "volume": "450",
            "issn": "3",
            "pages": "231--235",
            "other_ids": {
                "DOI": [
                    "10.1007/s00405-004-0796-y"
                ]
            }
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Phylogenetic network analysis of SARS-CoV-2 452 genomes",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Forster",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Forster",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Renfrew",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Forster",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Early Transmission Dynamics in Wuhan, China",
            "authors": [
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "SARS-CoV-2 Viral Load in Upper Respiratory Specimens of 460",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zou",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Ruan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Infected Patients",
            "authors": [],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "382",
            "issn": "12",
            "pages": "1177--1179",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMc2001737"
                ]
            }
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Non-neural expression of SARS-462",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "H"
                    ],
                    "last": "Brann",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tsukahara",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Weinreb",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "W"
                    ],
                    "last": "Logan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Datta",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in 463 COVID-19 patients",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "SARS-CoV-2 entry factors are highly expressed in 465 nasal epithelial cells together with innate immune genes",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Sungnak",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "B\u00e9cavin",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Evidence of the COVID-19 Virus Targeting the CNS",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Baig",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Khaleeq",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Ali",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Syeda",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms",
            "authors": [],
            "year": null,
            "venue": "ACS Chem",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Sendai Virus Induces Persistent Olfactory Dysfunction in a 471",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Tian",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Pinto",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Cui",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Murine Model of PVOD via Effects on Apoptosis, Cell Proliferation, and Response to 472",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Sudden and Complete Olfactory Loss Function as a 475",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Eliezer",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hautefort",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "L"
                    ],
                    "last": "Hamel",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Possible Symptom of COVID-19",
            "authors": [],
            "year": 2020,
            "venue": "JAMA",
            "volume": "476",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "High expression of ACE2 receptor of 2019-nCoV on the 478 epithelial cells of oral mucosa",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Deng",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Int J Oral Sci",
            "volume": "12",
            "issn": "1",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1038/s41368-020-0074-x"
                ]
            }
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Characteristics of COVID-19 Patients Presenting with Olfactory/ 501 Gustatory Dysfunction",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Table1",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Abbreviations: SD, standard deviation; IQR, interquartile range. a two patients in 504 China could not remember the date of onset of olfactory or gustatory dysfunction",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "211 designated by the government for the treatment of COVID-19 patients. A visual 212 analogue scale (VAS) of olfactory intensity and questionnaire of olfactory disorders 213 (QOD) were used to assess the presence and degree of hyposmia. The QOD-214 P(parosmic statements) evaluates the characteristic of the olfactory disorder, with a 215 high score indicating the presence of an olfactory disorder; QOD-QoL(quality of life) 216 evaluates quality of life, with a high score indicating a serious olfactory impairment; 217 QOD-DS(socially desired statements) evaluates reporter reliability, with a low score 218 indicating a tendency to give answers in line with perceived social expectations. 9 All 219 COVID-19 patients in Shanghai, China without subjective olfactory complaints 220 underwent objective olfactory testing with the following stimuli to screen for the 221 presence of subclinical hyposmia: eugenol (the smell of cloves -olfactory stimulus), 222 75% ethanol (trigeminal stimulus), and vinegar (mixed olfactory-trigeminal stimulus).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Sciences) version 26.0 software (SPSS Inc). Statistical significance was set at a 2-sided 251 \u03b1 of less than 0.05. Percentages were rounded to the nearest whole number. This study 252 was approved by the Institutional Ethics Committees of Shenzhen Third People's 253 Hospital, Wuhan Chinese and Western Medicine Hospital, and Shanghai Public Health 254 Clinical Center; the Ethics Committee of the University Clinic, TU Dresden; and the 255 Ethics Committee of Lariboisi\u00e8re University Hospital. 256 257 Results 258 Of the 394 COVID-19 patients screened for the study, 161 (41%) exhibited sudden 259 olfactory and/or gustatory dysfunction and were included. The incidence of olfactory 260 and/or gustatory complaints in COVID-19 patients in China, Germany and France is 261 32%, 69% and 49%, respectively (China VS Germany, P\uff1c0.001; China VS France, 262 P=0.002; Germany VS France, P=0.029). Sixty-one of 394 (15 %) of patients reported 263 isolated olfactory dysfunction and 7 of 394 (2%) reported isolated gustatory 264 dysfunction. Ninety-three of 394 (24%) patients had both olfactory and gustatory 265 dysfunction. Classification of COVID-19 severity was available for 278 observed 266 patient in China and Germany. The incidence of olfactory or taste dysfunction in mild, 267moderate and severely ill patients was 53/98 (54%), 40/107 (37%) and 11/63 (17%), 268 All rights reserved. No reuse allowed without permission.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "European countries (China VS Germany, P=0.001; China VS France, P \uff1c 0.001; 274 Germany VS France, P=0.165). There were no statistically significant differences in 275 gender among the three countries (China VS Germany, P=0.354; China VS France, 276 P=0.888; Germany VS France, P=0.321). Overall, seventy-eight of 161 (48%), 40/161 277 (25%), 33/161 (20%) and 10/161 (6%) were in mild, moderate, severe and critical 278 condition, respectively. However, distribution of disease severity in patients with 279 olfactory or gustatory dysfunction varied significantly between countries (China VS 280 Germany, P\uff1c0.001; China VS France, P\uff1c0.001; Germany VS France P\uff1c0.001). Of 281 the 161 patients, 156 were able to provide information on the timing and order of 282 symptom onset. Overall, 15/156 (10%) patients had olfactory or gustatory dysfunction 283 as their only symptom of COVID-19 infection. The percentage of patients with 284 olfactory or gustatory disorders as their only symptom in China, Germany and France 285 were 12%, 4% and 9%, respectively. Twenty-nine of 156 (19%) patients experienced 286 olfactory or gustatory dysfunction as the first symptom of their SARS-CoV-2 infection. 287",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "isolated olfactory dysfunction are documented to have infected others prior to 357 admission despite the robust screening and triage measures implemented at the time, 358 highlighting the potential danger. Adding questions about olfactory or gustatory 359 changes to routine screening measures would help identify these patients earlier, a boon 360 to infection control initiatives. Due to the inherent difficulties of COVID-19 patient 361 coordination, it is hard to perform T & T olfactometer test, though disposable olfactory 362 tests like the University of Pennsylvania Smell Identification Test (UPSIT) could be 363",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "and France. This study aims to systematically characterize and compare 192 olfactory and gustatory symptoms among COVID-19 adult patients and children in five 193 epidemic areas in Shanghai, Wuhan and Shenzhen [China], Paris [France] and Dresden 194 [Germany], emphasizing the importance of these symptoms as an early marker of 195 Through retrospective chart review, 394 COVID-19 patients presenting from March 199 15 th , 2020 to April 5 th , 2020 (141 cases in Shanghai, China; 62 cases in Wuhan, China; 200 36 cases in Shenzhen, China; 39 cases in Dresden, Germany; and 116 cases in Paris, 201",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Shanghai Public Health Clinical Center of Fudan 206 University, China (61 patients including 9 adolescents), Chinese and Western Medicine 207 Hospital of Tongji Medical College, Huazhong University of Science and Technology, 208 China (11 patients), Shenzhen Third People's Hospital, China (5 patients), Lariboisi\u00e8re 209 University Hospital, France (57 patients) and University Hospital at the TU Dresden, 210 Germany (27 patients including one adolescent). The three Chinese hospitals are",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "The Scores of VAS and QOD in COVID-19 Patients Presenting with 547Olfactory/Gustatory Dysfunction 548Abbreviations: VAS, visual analogue scale; QOD,the questionnaire of olfactory 549 disorders; SD, standard deviation; IQR, interquartile range; QoL, quality of life; DS, 550 socially desired statements; P, parosmic statements.All rights reserved. No reuse allowed without permission.",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "Characteristics of COVID-19 Positive Children Presenting with 582Olfactory/Gustatory Dysfunction 583",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}